Rytary ER 36.25 MG-145 MG cap 100S
Ended Awarded
- Contract number
- SPE2DB25FQ4N3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,771
Award facts
- Contract value 100% obligated
- $1,770.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,770.64 to AmerisourceBergen Drug Corp for RYTARY ER (extended-release carbidopa-levodopa) 36.25 mg-145 mg capsules in a quantity of 100 units. The order, executed on September 24, 2025, with an ultimate completion date of September 25, 2025, utilizes firm fixed pricing under a competitive, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order through its corporate office location at the same address, continuing its role as a critical pharmaceutical distributor for federal medical procurement.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The IDC serves as a comprehensive global pharmaceutical supply vehicle enabling the company to provide an extensive range of medications, including specialty pharmaceuticals, vaccines, and medical supplies to support military healthcare programs and related federal systems worldwide. The RYTARY ER delivery exemplifies the routine pharmaceutical fulfillment the company executes across the DLA's medical supply chain to support Defense Health Agency and other government healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FQ4N3?
SPE2DB25FQ4N3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FQ4N3 worth?
The government has obligated $1,771 on SPE2DB25FQ4N3.
Is contract SPE2DB25FQ4N3 an order under another contract?
Yes. SPE2DB25FQ4N3 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ4N3 competed?
The extent of competition for SPE2DB25FQ4N3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award